0.017241
0.000000
0.000000
0.000000
0.011655
0.000000
0.000000
0.000000
0.021505
0.00000
0.00000
0.00000
Backbro, K.
Unge, T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
58.000
85.800
46.500
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C32 H34 N2 O6 S
574.687
2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Med.Chem.
JMCMAR
0151
0022-2623
40
898
902
10.1021/jm960588d
9083478
Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor.
1997
10.2210/pdb1ajv/pdb
pdb_00001ajv
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
278
1
IMAGE PLATE
1995-05
MARRESEARCH
M
x-ray
1
0.9
1.0
DW32
LURE
0.9
SYNCHROTRON
LURE BEAMLINE DW32
10803.756
HIV-1 PROTEASE
3.4.23.16
2
man
polymer
574.687
2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL
1
syn
non-polymer
18.015
water
75
nat
water
no
no
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Lentivirus
BH10
Escherichia
Escherichia coli
sample
BL21
PROTEASE
11676
Human immunodeficiency virus 1
PROTEASE
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PET11C
1
2.8
54.03
VAPOR DIFFUSION
5.5
CRYSTALLIZATION WAS PERFORMED BY VAPOR DIFFUSION. PROTEASE (2 MG/ML) AND INHIBITOR (40 MM IN DMSO) WAS MIXED IN A RATIO OF 1:1 AND SUBJECTED TO COCRYSTALLIZATION. DROPS CONSISTING OF 5 MICROLITERS OF THE PROTEASE-INHIBITOR MIXTURE PLUS 5 MICROLITERS OF THE CRYSTALLIZATION BUFFER (50 MM MES PH 5.5, 0.4 M NACL AND 0.02% (W/V) NAN3) WERE EQUILIBRATED AGAINST THE SAME BUFFER AT 4 DEGREES C., vapor diffusion, temperature 277K
277
database_2
pdbx_database_status
pdbx_initial_refinement_model
struct_site
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Refinement description
1
0
1997-08-20
1
1
2008-03-24
1
2
2011-07-13
1
3
2023-08-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1997-05-11
REL
REL
NMB
2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL
HOH
water
4PHV
PDB ENTRY 4PHV
PDB
experimental model
NMB
501
2
NMB
NMB
501
A
HOH
302
3
HOH
HOH
302
A
HOH
303
3
HOH
HOH
303
A
HOH
307
3
HOH
HOH
307
A
HOH
309
3
HOH
HOH
309
A
HOH
312
3
HOH
HOH
312
A
HOH
313
3
HOH
HOH
313
A
HOH
317
3
HOH
HOH
317
A
HOH
318
3
HOH
HOH
318
A
HOH
321
3
HOH
HOH
321
A
HOH
324
3
HOH
HOH
324
A
HOH
325
3
HOH
HOH
325
A
HOH
328
3
HOH
HOH
328
A
HOH
331
3
HOH
HOH
331
A
HOH
334
3
HOH
HOH
334
A
HOH
339
3
HOH
HOH
339
A
HOH
341
3
HOH
HOH
341
A
HOH
342
3
HOH
HOH
342
A
HOH
343
3
HOH
HOH
343
A
HOH
344
3
HOH
HOH
344
A
HOH
345
3
HOH
HOH
345
A
HOH
347
3
HOH
HOH
347
A
HOH
348
3
HOH
HOH
348
A
HOH
349
3
HOH
HOH
349
A
HOH
352
3
HOH
HOH
352
A
HOH
359
3
HOH
HOH
359
A
HOH
361
3
HOH
HOH
361
A
HOH
363
3
HOH
HOH
363
A
HOH
301
3
HOH
HOH
301
B
HOH
304
3
HOH
HOH
304
B
HOH
305
3
HOH
HOH
305
B
HOH
306
3
HOH
HOH
306
B
HOH
308
3
HOH
HOH
308
B
HOH
310
3
HOH
HOH
310
B
HOH
311
3
HOH
HOH
311
B
HOH
314
3
HOH
HOH
314
B
HOH
315
3
HOH
HOH
315
B
HOH
316
3
HOH
HOH
316
B
HOH
319
3
HOH
HOH
319
B
HOH
320
3
HOH
HOH
320
B
HOH
322
3
HOH
HOH
322
B
HOH
323
3
HOH
HOH
323
B
HOH
326
3
HOH
HOH
326
B
HOH
327
3
HOH
HOH
327
B
HOH
329
3
HOH
HOH
329
B
HOH
330
3
HOH
HOH
330
B
HOH
332
3
HOH
HOH
332
B
HOH
333
3
HOH
HOH
333
B
HOH
335
3
HOH
HOH
335
B
HOH
336
3
HOH
HOH
336
B
HOH
337
3
HOH
HOH
337
B
HOH
338
3
HOH
HOH
338
B
HOH
340
3
HOH
HOH
340
B
HOH
346
3
HOH
HOH
346
B
HOH
350
3
HOH
HOH
350
B
HOH
351
3
HOH
HOH
351
B
HOH
353
3
HOH
HOH
353
B
HOH
354
3
HOH
HOH
354
B
HOH
355
3
HOH
HOH
355
B
HOH
356
3
HOH
HOH
356
B
HOH
357
3
HOH
HOH
357
B
HOH
358
3
HOH
HOH
358
B
HOH
360
3
HOH
HOH
360
B
HOH
362
3
HOH
HOH
362
B
HOH
364
3
HOH
HOH
364
B
HOH
365
3
HOH
HOH
365
B
HOH
366
3
HOH
HOH
366
B
HOH
367
3
HOH
HOH
367
B
HOH
368
3
HOH
HOH
368
B
HOH
369
3
HOH
HOH
369
B
HOH
370
3
HOH
HOH
370
B
HOH
371
3
HOH
HOH
371
B
HOH
372
3
HOH
HOH
372
B
HOH
373
3
HOH
HOH
373
B
HOH
374
3
HOH
HOH
374
B
HOH
375
3
HOH
HOH
375
B
PRO
1
n
1
PRO
1
A
GLN
2
n
2
GLN
2
A
ILE
3
n
3
ILE
3
A
THR
4
n
4
THR
4
A
LEU
5
n
5
LEU
5
A
TRP
6
n
6
TRP
6
A
GLN
7
n
7
GLN
7
A
ARG
8
n
8
ARG
8
A
PRO
9
n
9
PRO
9
A
LEU
10
n
10
LEU
10
A
VAL
11
n
11
VAL
11
A
THR
12
n
12
THR
12
A
ILE
13
n
13
ILE
13
A
LYS
14
n
14
LYS
14
A
ILE
15
n
15
ILE
15
A
GLY
16
n
16
GLY
16
A
GLY
17
n
17
GLY
17
A
GLN
18
n
18
GLN
18
A
LEU
19
n
19
LEU
19
A
LYS
20
n
20
LYS
20
A
GLU
21
n
21
GLU
21
A
ALA
22
n
22
ALA
22
A
LEU
23
n
23
LEU
23
A
LEU
24
n
24
LEU
24
A
ASP
25
n
25
ASP
25
A
THR
26
n
26
THR
26
A
GLY
27
n
27
GLY
27
A
ALA
28
n
28
ALA
28
A
ASP
29
n
29
ASP
29
A
ASP
30
n
30
ASP
30
A
THR
31
n
31
THR
31
A
VAL
32
n
32
VAL
32
A
LEU
33
n
33
LEU
33
A
GLU
34
n
34
GLU
34
A
GLU
35
n
35
GLU
35
A
MET
36
n
36
MET
36
A
SER
37
n
37
SER
37
A
LEU
38
n
38
LEU
38
A
PRO
39
n
39
PRO
39
A
GLY
40
n
40
GLY
40
A
ARG
41
n
41
ARG
41
A
TRP
42
n
42
TRP
42
A
LYS
43
n
43
LYS
43
A
PRO
44
n
44
PRO
44
A
LYS
45
n
45
LYS
45
A
MET
46
n
46
MET
46
A
ILE
47
n
47
ILE
47
A
GLY
48
n
48
GLY
48
A
GLY
49
n
49
GLY
49
A
ILE
50
n
50
ILE
50
A
GLY
51
n
51
GLY
51
A
GLY
52
n
52
GLY
52
A
PHE
53
n
53
PHE
53
A
ILE
54
n
54
ILE
54
A
LYS
55
n
55
LYS
55
A
VAL
56
n
56
VAL
56
A
ARG
57
n
57
ARG
57
A
GLN
58
n
58
GLN
58
A
TYR
59
n
59
TYR
59
A
ASP
60
n
60
ASP
60
A
GLN
61
n
61
GLN
61
A
ILE
62
n
62
ILE
62
A
LEU
63
n
63
LEU
63
A
ILE
64
n
64
ILE
64
A
GLU
65
n
65
GLU
65
A
ILE
66
n
66
ILE
66
A
CYS
67
n
67
CYS
67
A
GLY
68
n
68
GLY
68
A
HIS
69
n
69
HIS
69
A
LYS
70
n
70
LYS
70
A
ALA
71
n
71
ALA
71
A
ILE
72
n
72
ILE
72
A
GLY
73
n
73
GLY
73
A
THR
74
n
74
THR
74
A
VAL
75
n
75
VAL
75
A
LEU
76
n
76
LEU
76
A
VAL
77
n
77
VAL
77
A
GLY
78
n
78
GLY
78
A
PRO
79
n
79
PRO
79
A
THR
80
n
80
THR
80
A
PRO
81
n
81
PRO
81
A
VAL
82
n
82
VAL
82
A
ASN
83
n
83
ASN
83
A
ILE
84
n
84
ILE
84
A
ILE
85
n
85
ILE
85
A
GLY
86
n
86
GLY
86
A
ARG
87
n
87
ARG
87
A
ASN
88
n
88
ASN
88
A
LEU
89
n
89
LEU
89
A
LEU
90
n
90
LEU
90
A
THR
91
n
91
THR
91
A
GLN
92
n
92
GLN
92
A
ILE
93
n
93
ILE
93
A
GLY
94
n
94
GLY
94
A
CYS
95
n
95
CYS
95
A
THR
96
n
96
THR
96
A
LEU
97
n
97
LEU
97
A
ASN
98
n
98
ASN
98
A
PHE
99
n
99
PHE
99
A
PRO
1
n
1
PRO
1
B
GLN
2
n
2
GLN
2
B
ILE
3
n
3
ILE
3
B
THR
4
n
4
THR
4
B
LEU
5
n
5
LEU
5
B
TRP
6
n
6
TRP
6
B
GLN
7
n
7
GLN
7
B
ARG
8
n
8
ARG
8
B
PRO
9
n
9
PRO
9
B
LEU
10
n
10
LEU
10
B
VAL
11
n
11
VAL
11
B
THR
12
n
12
THR
12
B
ILE
13
n
13
ILE
13
B
LYS
14
n
14
LYS
14
B
ILE
15
n
15
ILE
15
B
GLY
16
n
16
GLY
16
B
GLY
17
n
17
GLY
17
B
GLN
18
n
18
GLN
18
B
LEU
19
n
19
LEU
19
B
LYS
20
n
20
LYS
20
B
GLU
21
n
21
GLU
21
B
ALA
22
n
22
ALA
22
B
LEU
23
n
23
LEU
23
B
LEU
24
n
24
LEU
24
B
ASP
25
n
25
ASP
25
B
THR
26
n
26
THR
26
B
GLY
27
n
27
GLY
27
B
ALA
28
n
28
ALA
28
B
ASP
29
n
29
ASP
29
B
ASP
30
n
30
ASP
30
B
THR
31
n
31
THR
31
B
VAL
32
n
32
VAL
32
B
LEU
33
n
33
LEU
33
B
GLU
34
n
34
GLU
34
B
GLU
35
n
35
GLU
35
B
MET
36
n
36
MET
36
B
SER
37
n
37
SER
37
B
LEU
38
n
38
LEU
38
B
PRO
39
n
39
PRO
39
B
GLY
40
n
40
GLY
40
B
ARG
41
n
41
ARG
41
B
TRP
42
n
42
TRP
42
B
LYS
43
n
43
LYS
43
B
PRO
44
n
44
PRO
44
B
LYS
45
n
45
LYS
45
B
MET
46
n
46
MET
46
B
ILE
47
n
47
ILE
47
B
GLY
48
n
48
GLY
48
B
GLY
49
n
49
GLY
49
B
ILE
50
n
50
ILE
50
B
GLY
51
n
51
GLY
51
B
GLY
52
n
52
GLY
52
B
PHE
53
n
53
PHE
53
B
ILE
54
n
54
ILE
54
B
LYS
55
n
55
LYS
55
B
VAL
56
n
56
VAL
56
B
ARG
57
n
57
ARG
57
B
GLN
58
n
58
GLN
58
B
TYR
59
n
59
TYR
59
B
ASP
60
n
60
ASP
60
B
GLN
61
n
61
GLN
61
B
ILE
62
n
62
ILE
62
B
LEU
63
n
63
LEU
63
B
ILE
64
n
64
ILE
64
B
GLU
65
n
65
GLU
65
B
ILE
66
n
66
ILE
66
B
CYS
67
n
67
CYS
67
B
GLY
68
n
68
GLY
68
B
HIS
69
n
69
HIS
69
B
LYS
70
n
70
LYS
70
B
ALA
71
n
71
ALA
71
B
ILE
72
n
72
ILE
72
B
GLY
73
n
73
GLY
73
B
THR
74
n
74
THR
74
B
VAL
75
n
75
VAL
75
B
LEU
76
n
76
LEU
76
B
VAL
77
n
77
VAL
77
B
GLY
78
n
78
GLY
78
B
PRO
79
n
79
PRO
79
B
THR
80
n
80
THR
80
B
PRO
81
n
81
PRO
81
B
VAL
82
n
82
VAL
82
B
ASN
83
n
83
ASN
83
B
ILE
84
n
84
ILE
84
B
ILE
85
n
85
ILE
85
B
GLY
86
n
86
GLY
86
B
ARG
87
n
87
ARG
87
B
ASN
88
n
88
ASN
88
B
LEU
89
n
89
LEU
89
B
LEU
90
n
90
LEU
90
B
THR
91
n
91
THR
91
B
GLN
92
n
92
GLN
92
B
ILE
93
n
93
ILE
93
B
GLY
94
n
94
GLY
94
B
CYS
95
n
95
CYS
95
B
THR
96
n
96
THR
96
B
LEU
97
n
97
LEU
97
B
ASN
98
n
98
ASN
98
B
PHE
99
n
99
PHE
99
B
author_and_software_defined_assembly
PISA
2
dimeric
4870
-32
9100
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
11
A
O
VAL
11
A
N
ALA
22
A
N
ALA
22
A
O
LYS
43
A
O
LYS
43
A
N
GLN
58
A
N
GLN
58
A
O
ARG
57
A
O
ARG
57
A
N
VAL
77
A
N
VAL
77
A
O
ILE
62
A
O
ILE
62
A
N
GLY
73
A
N
GLY
73
B
O
GLN
18
B
O
GLN
18
B
N
ILE
15
B
N
ILE
15
B
O
LYS
14
B
O
LYS
14
B
N
GLU
65
B
N
GLU
65
B
O
ILE
62
B
O
ILE
62
B
N
GLY
73
B
N
GLY
73
B
O
LYS
43
B
O
LYS
43
B
N
GLN
58
B
N
GLN
58
B
O
ARG
57
B
O
ARG
57
B
N
VAL
77
B
N
VAL
77
1
A
PRO
79
-73.29
49.22
PARHCSDX.PRO
TOPHCSDX.PRO
AHA006.PAR
AHA006.TOP
17.
0.2470000
0.1870000
0.1870000
2.00
8.00
14846
10.
91.7
RANDOM
1
THROUGHOUT
2.0
MOLECULAR REPLACEMENT
PDB ENTRY 4PHV
2.00
8.00
75
1962
41
0
1846
0.010
1.90
25.5
1.32
0.0880000
2.07
1397
10
88.2
2.0
25.0
1AJV
14846
2.
0.0410000
1
91.7
0.0880000
2.0
2.07
80.
model building
X-PLOR
refinement
X-PLOR
3.1
data reduction
DENZO
data scaling
SCALEPACK
phasing
X-PLOR
HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006
1
N
N
1
N
N
2
N
N
3
N
N
3
N
N
A
ARG
87
A
ARG
87
HELX_P
A
LEU
90
A
LEU
90
1
1
4
B
ARG
87
B
ARG
87
HELX_P
B
LEU
90
B
LEU
90
1
2
4
ASPARTYL PROTEASE
PROTEASE, ASPARTYL PROTEASE, NON-PEPTIDE INHIBITOR, DRUG DESIGN, HIV-1
POL_HV1B1
UNP
1
1
P03366
FFREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGRDNNSPSEAGADRQGTVSFNFPQITLWQRPLVT
IKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQ
IGCTLNFPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK
LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGW
KGSPAIFQSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYE
LHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP
VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPI
QKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTT
NQKTELQAIYLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS
AGIRKILFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVI
LVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVES
MNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP
LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED
69
167
1AJV
1
99
P03366
A
1
1
99
69
167
1AJV
1
99
P03366
B
1
1
99
2
3
2
4
3
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LEU
10
A
LEU
10
A
ILE
15
A
ILE
15
A
GLN
18
A
GLN
18
A
LEU
23
A
LEU
23
A
LYS
43
A
LYS
43
A
GLY
49
A
GLY
49
A
GLY
52
A
GLY
52
A
TYR
59
A
TYR
59
A
VAL
75
A
VAL
75
A
GLY
78
A
GLY
78
A
ILE
62
A
ILE
62
A
ILE
66
A
ILE
66
A
HIS
69
A
HIS
69
A
GLY
73
A
GLY
73
B
GLN
18
B
GLN
18
B
LEU
23
B
LEU
23
B
LEU
10
B
LEU
10
B
ILE
15
B
ILE
15
B
ILE
62
B
ILE
62
B
ILE
66
B
ILE
66
B
HIS
69
B
HIS
69
B
GLY
73
B
GLY
73
B
LYS
43
B
LYS
43
B
GLY
49
B
GLY
49
B
GLY
52
B
GLY
52
B
TYR
59
B
TYR
59
B
VAL
75
B
VAL
75
B
VAL
77
B
VAL
77
BINDING SITE FOR RESIDUE NMB A 501
A
NMB
501
Software
19
A
ASP
25
A
ASP
25
19
1_555
A
GLY
27
A
GLY
27
19
1_555
A
ALA
28
A
ALA
28
19
1_555
A
GLY
48
A
GLY
48
19
1_555
A
GLY
49
A
GLY
49
19
1_555
A
ILE
50
A
ILE
50
19
1_555
A
VAL
82
A
VAL
82
19
1_555
B
LEU
23
B
LEU
23
19
1_555
B
ASP
25
B
ASP
25
19
1_555
B
GLY
27
B
GLY
27
19
1_555
B
ALA
28
B
ALA
28
19
1_555
B
ASP
29
B
ASP
29
19
1_555
B
ASP
30
B
ASP
30
19
1_555
B
VAL
32
B
VAL
32
19
1_555
B
GLY
48
B
GLY
48
19
1_555
B
GLY
49
B
GLY
49
19
1_555
B
ILE
50
B
ILE
50
19
1_555
B
PRO
81
B
PRO
81
19
1_555
B
HOH
301
E
HOH
19
1_555
18
P 21 21 2